In the manufacturing process for antigen receptor T cell (CAR-T cell) therapies, the patient's T cells acquire medicinal status after enrichment, genetic modification, and expansion.
CITATION STYLE
Rioufol, C., & Wichmann, C. (2022). Receiving, handling, storage, thawing, distribution, and administration of CAR-T cells shipped from the manufacturing facility. In The EBMT/EHA CAR-T Cell Handbook (pp. 37–43). Springer International Publishing. https://doi.org/10.1007/978-3-030-94353-0_7
Mendeley helps you to discover research relevant for your work.